News and Trends 20 Jul 2018 Belgian Biotech Completes First Trial with New Drug for Diabetic Macular Edema …treatment for diabetic macular edema. ThromboGenics is currently enrolling patients for a Phase II study combining the antibody with anti-VEGF, a drug used to treat diabetic macular edema. If it… July 20, 2018 - 2 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 19 Sep 2022 CellResearch Corporation announces positive results of phase I diabetic foot ulcer study …University of Colorado, Anschutz Medical Campus. About diabetic foot ulcers Acoording to University of Michigan Health, a diabetic foot ulcer is an open sore or wound that occurs in approximately… September 19, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 2 Aug 2022 Enrollment completed for trial looking at treatment of diabetic kidney disease Enrollment has been completed for a study of a regenerative cell therapy investigational product for intra-renal artery administration to treat diabetic kidney disease (DKD). U.S.-based Caladrius Biosciences Inc., a clinical-stage… August 2, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 28 Sep 2022 Ilya Pharma enrols first patient in diabetic foot ulcer study Ilya Pharma AB says the first patients have been enrolled in a phase II study for its lead candidate ILP100-Topical in patients with diabetic foot ulcers. Overall, up to 13%… September 28, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 3 Nov 2022 New method to treat diabetic foot ulcers revealed by Biocomposites Ltd Diabetic foot infection costs the UK’s NHS around £900 million ($990 million) a year, bringing severe misery to patients. Usually, systemic antibiotics are routinely given to those with diabetes who… November 3, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 23 Jun 2017 Diabetic Patients that Still Produce Insulin might be the Key to a New Therapy A study from Uppsala University has identified higher levels of interleukin-35 in type 1 diabetics that still produce insulin years after their diagnosis. Researchers at Uppsala University have published the… June 23, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 5 Jul 2019 French Biotech’s Plant Extract Cuts Blood Glucose in Prediabetic People …reducing risk factors for type 2 diabetes in prediabetic people. Valbiotis’ supplement is a combination of extracts from five undisclosed plants that have an effect on key organs such as… July 5, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 26 Jan 2023 Orbsen Therapeutics happy with interim diabetic kidney disease study results Orbsen Therapeutics Limited has announced what it says are encouraging headline interim results from the EU Horizon 2020-funded NEPHSTROM clinical trial for diabetic kidney disease. NEPHSTROM is a randomized, double-blind,… January 26, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 25 Jan 2018 What Happened to the Plans for a Smart Contact Lens for Diabetics? …and more comprehensive way of monitoring the glucose levels of diabetics compared to the current techniques, which include drawing blood from the finger of the patient. The technology has the… January 25, 2018 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 27 Jan 2017 Bad News for Diabetics: Eli Lilly Abandons French Ultra-Rapid Insulin …riskier, more innovative product, Lilly’s position in the diabetes market will now mostly rely on Abasaglar, its biosimilar of Lantus. For both Adocia and diabetics worldwide, this decision brings bad… January 27, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 6 Sep 2018 Insulin Combo Reduces After-Meal Sugar Spikes in Type 1 Diabetics …after a meal. The trial, which recruited 24 type 1 diabetics, studied the effect of Adocia’s BioChaperone pramlintide insulin on glucose levels right after a meal. It combines insulin… September 6, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 7 Nov 2016 The Mind Behind the Artificial Pancreas that Could Change the Lives of Diabetics …is no way patients can know what they need.” Irregular blood-glucose levels can have serious long-term complications that include blindness, diabetic foot and heart disease. Therefore, health systems will be… November 7, 2016 - 5 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email